These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cells. Getachew R, Ballinger ML, Burch ML, Little PJ, Osman N. Eur J Pharmacol; 2010 Jan 25; 626(2-3):186-92. PubMed ID: 19818754 [Abstract] [Full Text] [Related]
3. Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents. de Dios ST, Frontanilla KV, Nigro J, Ballinger ML, Ivey ME, Cawson EA, Little PJ. J Diabetes Complications; 2007 Jan 25; 21(2):108-17. PubMed ID: 17331859 [Abstract] [Full Text] [Related]
4. Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL. Ballinger ML, Ivey ME, Osman N, Thomas WG, Little PJ. Atherosclerosis; 2009 Aug 25; 205(2):451-7. PubMed ID: 19217622 [Abstract] [Full Text] [Related]
5. Androgens stimulate human vascular smooth muscle cell proteoglycan biosynthesis and increase lipoprotein binding. Hashimura K, Sudhir K, Nigro J, Ling S, Williams MR, Komesaroff PA, Little PJ. Endocrinology; 2005 Apr 25; 146(4):2085-90. PubMed ID: 15661861 [Abstract] [Full Text] [Related]
6. Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein binding. Ballinger ML, Osman N, Wilks AF, Su S, Burns CJ, Bu X, Little PJ. J Cardiovasc Pharmacol; 2008 Nov 25; 52(5):403-12. PubMed ID: 19033819 [Abstract] [Full Text] [Related]
7. Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor beta type I receptor. Burch ML, Ballinger ML, Yang SNY, Getachew R, Itman C, Loveland K, Osman N, Little PJ. J Biol Chem; 2010 Aug 27; 285(35):26798-26805. PubMed ID: 20571025 [Abstract] [Full Text] [Related]
8. Effect of endothelial-cell-conditioned medium on proteoglycan synthesis in cultured smooth muscle cells from pig aorta. Berrou E, Breton M, Deudon E, Picard J. J Cell Physiol; 1988 Dec 27; 137(3):430-8. PubMed ID: 3142885 [Abstract] [Full Text] [Related]
16. Transcriptional inhibition of protease-activated receptor-1 expression by prostacyclin in human vascular smooth muscle cells. Pape R, Rauch BH, Rosenkranz AC, Kaber G, Schrör K. Arterioscler Thromb Vasc Biol; 2008 Mar 27; 28(3):534-40. PubMed ID: 18162607 [Abstract] [Full Text] [Related]
17. Genistein inhibits PDGF-stimulated proteoglycan synthesis in vascular smooth muscle without blocking PDGFβ receptor phosphorylation. Little PJ, Getachew R, Rezaei HB, Sanchez-Guerrero E, Khachigian LM, Wang H, Liao S, Zheng W, Ballinger ML, Osman N. Arch Biochem Biophys; 2012 Sep 01; 525(1):25-31. PubMed ID: 22683649 [Abstract] [Full Text] [Related]
18. Differential effects of cadmium on proteoglycan synthesis of arterial smooth muscle cells: increase in small dermatan sulfate proteoglycans, biglycan and decorin, in the extracellular matrix at low cell density. Fujiwara Y, Tsumura N, Yamamoto C, Kaji T. Toxicology; 2002 Jan 15; 170(1-2):89-101. PubMed ID: 11750086 [Abstract] [Full Text] [Related]
19. Endothelin-1 stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by endothelin receptor transactivation of the transforming growth factor-[beta] type I receptor. Little PJ, Burch ML, Getachew R, Al-aryahi S, Osman N. J Cardiovasc Pharmacol; 2010 Oct 15; 56(4):360-8. PubMed ID: 20625315 [Abstract] [Full Text] [Related]
20. Lysophosphatidylcholine regulates synthesis of biglycan and the proteoglycan form of macrophage colony stimulating factor. Chang MY, Tsoi C, Wight TN, Chait A. Arterioscler Thromb Vasc Biol; 2003 May 01; 23(5):809-15. PubMed ID: 12663372 [Abstract] [Full Text] [Related] Page: [Next] [New Search]